Nonoperating Income (Expense) of FibroBiologics, Inc. from 31 Mar 2023 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
FibroBiologics, Inc. annual and quarterly Nonoperating Income (Expense) in USD history and change rate from 31 Mar 2023 to 31 Dec 2025.
  • FibroBiologics, Inc. Nonoperating Income (Expense) for the quarter ending 30 Sep 2025 was $740,000, a 126% decline year-over-year.
  • FibroBiologics, Inc. annual Nonoperating Income (Expense) for 2025 was $1,997,000, a 178% decline from 2024.
  • FibroBiologics, Inc. annual Nonoperating Income (Expense) for 2024 was $2,576,000.
Source SEC data
View on sec.gov
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)

FibroBiologics, Inc. Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $1,997,000 -$4,573,000 -178% 01 Jan 2025 31 Dec 2025 10-K 24 Feb 2026 2025 FY
2024 $2,576,000 +$2,789,000 01 Jan 2024 31 Dec 2024 10-K 24 Feb 2026 2025 FY
2023 $213,000 01 Jan 2023 31 Dec 2023 10-K 29 Feb 2024 2023 FY

FibroBiologics, Inc. Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $740,000 -$3,592,000 -126% 01 Jul 2025 30 Sep 2025 10-Q 31 Oct 2025 2025 Q3
Q3 2024 $2,852,000 +$2,993,000 01 Jul 2024 30 Sep 2024 10-Q 31 Oct 2025 2025 Q3
Q3 2023 $141,000 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q1 2023 $15,000 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.